Kestra Medical Technologies, Ltd. (KMTS)

NASDAQ: KMTS · Real-Time Price · USD

29.81

+0.12 (0.40%)

At close: Nov 2, 2026, 4:00 PM EST

29.81

0.00 (0.00%)

After-hours: Nov 2, 2026, 7:30 PM EST

KMTS Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '21 Apr 30, 2021
Revenue	106.73	95.13	59.82	27.81	7.63	-
Revenue Growth	60.72%	59.03%	115.05%	264.54%	-	-
Cost of Revenue	49.22	46.26	35.61	27.45	18.28	-
Gross Profit	57.51	48.86	24.21	0.36	-10.65	-
Selling, General & Admin	178.75	164.12	114.94	69.94	54.01	13.9
Research & Development	22.28	19.48	15.65	15.49	15.76	18.81
Operating Expenses	201.03	183.6	130.59	85.43	69.77	32.71
Operating Income	-143.52	-134.74	-106.38	-85.06	-80.42	-32.71
Interest Expense	-7.56	-7.55	-7.73	-6.23	-5.63	-1.17
Interest & Investment Income	8.31	8.35	3.2	-	-	-
Other Non Operating Income (Expenses)	-0.48	2.62	-2.77	-0.09	1.83	-0.04
EBT Excluding Unusual Items	-143.26	-131.32	-113.68	-91.38	-84.22	-33.91
Other Unusual Items	-6.3	-	-	-2.72	-	-
Pretax Income	-149.56	-131.32	-113.68	-94.1	-84.22	-33.91
Income Tax Expense	0.31	0.29	0.14	0.02	0.02	0.19
Net Income	-149.87	-131.61	-113.81	-94.12	-84.24	-34.1
Preferred Dividends & Other Adjustments	-	-	12.32	6.72	2.5	-
Net Income to Common	-149.87	-131.61	-126.14	-100.84	-86.74	-34.1
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	56	54	25	20	0	0
Shares Outstanding (Diluted)	56	54	25	20	0	0
Shares Change	72.64%	120.41%	23.63%	18693.84%	-	-
EPS (Basic)	-2.68	-2.43	-5.13	-5.07	-819.76	-322.29
EPS (Diluted)	-2.68	-2.43	-5.13	-5.07	-819.76	-322.29
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '21 Apr 30, 2021
Free Cash Flow	-123.21	-117.12	-101.2	-84.75	-85.1	-30.23
Free Cash Flow Per Share	-2.20	-2.16	-4.12	-4.26	-804.32	-285.72
Gross Margin	53.89%	51.37%	40.48%	1.30%	-139.59%	-
Operating Margin	-134.47%	-141.65%	-177.84%	-305.83%	-1054.01%	-
Profit Margin	-140.43%	-138.36%	-210.88%	-362.56%	-1136.79%	-
Free Cash Flow Margin	-115.44%	-123.12%	-169.19%	-304.70%	-1115.37%	-
EBITDA	-134.18	-126.03	-98.41	-73.5	-75.57	-32.29
EBITDA Margin	-125.72%	-132.49%	-164.52%	-264.27%	-	-
D&A For EBITDA	9.35	8.71	7.97	11.56	4.86	0.42
EBIT	-143.52	-134.74	-106.38	-85.06	-80.42	-32.71
EBIT Margin	-134.47%	-141.65%	-177.84%	-	-	-

SEC Filings: 10-K · 10-Q